ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.8969 ↓ -0.3%
[as on 11 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 11 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 16.97% -0.3% 0.22% -0.97% 9.44% 11.86% 19.81%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.55% -0.61% -1.77% -6.48% 0.55% -13.4% 4.69% 12.12% 15.55% 13.48%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.09% -0.49% -2.13% -4.09% 3.04% -1.59% 8.1% 8.16% 13.27% 11.45%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 25.1% -0.28% 0.76% -0.34% 11.62% 21.41% 24.25% 18.68% 25.98% 14.82%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 0.9% -0.52% -0.99% -2.51% 2.23% 4.49% 13.03% 16.01% 19.85% 15.13%
SBI COMMA Fund - DIRECT PLAN - Growth 6.56% -1.27% -2.15% -0.7% 4.16% 12.2% 15.12% 11.14% 20.13% 15.56%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -6.9% 35.22% 44.46% -9.08%

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns -1.03% -2.44% -6.81% 6.98% -4.59% 7.71% 3.1% 5.95% 4.02% 2.89%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 5.41%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.89% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.11%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.26%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.97%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.05%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.05%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.84%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.43%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.41%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.21%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.84%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.39%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.04%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.03%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.98%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.82%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.79%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology1.90%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.52%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services1.35%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.32%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.27%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Consumer Durables1.23%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.21%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.15%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals1.10%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.09%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.05%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.95%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.93%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.92%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing0.88%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.72%
Venus Pipes And Tubes LimitedVENUSPIPES (INE0JA001018)Industrial Products0.69%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.61%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.54%
Bharat Dynamics LimitedBDL (INE171Z01026)Aerospace & Defense0.47%
Yes Bank LimitedYESBANK (INE528G01035)Banks0.46%

Debt

NameRatingWeight %
Portfolio data is as on date 31 July, 2026

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 September, 202619.8969 -0.3%
10 September, 202619.9577 -0.46%
9 September, 202620.0493 -0.25%
8 September, 202620.0994 0.83%
7 September, 202619.9341 0.41%
4 September, 202619.8534 -0.61%
3 September, 202619.9760 -0.18%
2 September, 202620.0127 -0.09%
1 September, 202620.0303 -1.26%
31 August, 202620.2852 0.89%
28 August, 202620.1064 0.25%
27 August, 202620.0566 0.59%
26 August, 202619.9384 0.39%
25 August, 202619.8605 0.8%
24 August, 202619.7022 -0.19%
21 August, 202619.7405 -0.42%
20 August, 202619.8240 0.31%
19 August, 202619.7621 -0.33%
18 August, 202619.8280 0.39%
17 August, 202619.7511 -0.35%
14 August, 202619.8213 -0.31%
13 August, 202619.8837 -0.23%
12 August, 202619.9290 -0.81%
11 August, 202620.0910 0.46%
10 August, 202619.9985 0.09%
7 August, 202619.9801 0.4%
6 August, 202619.9011 0.4%
5 August, 202619.8226 0.15%
4 August, 202619.7923 -0.11%
3 August, 202619.8134

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 19.8969 as on 11 September, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 16.97% as on 11 September, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 11.86% as on 11 September, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 19.81% as on 11 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.